ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -92.4% | 0.00% | – |
| Q1 2020 | $4,000 | +33.3% | 79 | +41.1% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -50.0% | 56 | -44.0% | 0.00% | – |
| Q1 2019 | $10,000 | -69.7% | 100 | -74.2% | 0.00% | – |
| Q3 2018 | $33,000 | -84.1% | 387 | -78.5% | 0.00% | -100.0% |
| Q2 2018 | $208,000 | +3366.7% | 1,798 | +1698.0% | 0.00% | – |
| Q4 2017 | $6,000 | -82.9% | 100 | -87.1% | 0.00% | – |
| Q2 2015 | $35,000 | +45.8% | 778 | 0.0% | 0.00% | – |
| Q1 2015 | $24,000 | +300.0% | 778 | +380.2% | 0.00% | – |
| Q3 2014 | $6,000 | +100.0% | 162 | +161.3% | 0.00% | – |
| Q2 2014 | $3,000 | +200.0% | 62 | +181.8% | 0.00% | – |
| Q1 2014 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |